Drug intelligence / Profile preview

Sham PC-TEAS

Development stage: Unknown
Administration: Transdermal

Overview

Sham PC-TEAS (Patient-Controlled Transcutaneous Electrical Acupoint Stimulation) is a control intervention used in clinical trials to evaluate the efficacy of true PC-TEAS therapy. It mimics the appearance and procedure of the active treatment but does not deliver actual electrical stimulation. In sham PC-TEAS, the device has normal screen displays but uses nonconductive gel patches that prevent the normal output of current, making it an inactive comparator. This placebo control helps researchers determine the specific therapeutic effects of true PC-TEAS beyond placebo effects in conditions such as cancer-induced bone pain.

Beyond the preview

Go deeper on Sham PC-TEAS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sham PC-TEAS.

Explore the full profile